ONCOBIX Trademark

Trademark Overview

On Tuesday, October 12, 2021, a trademark application was filed for ONCOBIX with the United States Patent and Trademark Office. The USPTO has given the ONCOBIX trademark a serial number of 79325451. The federal status of this trademark filing is REGISTERED as of Tuesday, June 6, 2023. This trademark is owned by ONCOBIX CO., LTD.. The ONCOBIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents for epidermis; Pharmaceutical preparations for diagnosing cancer; Antibiotic preparations; Veterinary preparations, namely, diagnostic preparations for veterinary purposes; Pharmaceutical preparations for activating cellular function; human vaccine preparations; Anti-cancer preparations; Veterinary vaccines; Pharmaceutical agents for treating physically caused lesions; Bacteriological preparations for medical and veterinary use; Preparations of microorganisms for medical purposes; Bacterial preparations for medical purposes
oncobix

General Information

Serial Number79325451
Word MarkONCOBIX
Filing DateTuesday, October 12, 2021
Status700 - REGISTERED
Status DateTuesday, June 6, 2023
Registration Number7070573
Registration DateTuesday, June 6, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Description of MarkThe mark consists of the stylized term "ONCOBIX."
Goods and ServicesPharmaceutical products for the treatment of cancer; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents for epidermis; Pharmaceutical preparations for diagnosing cancer; Antibiotic preparations; Veterinary preparations, namely, diagnostic preparations for veterinary purposes; Pharmaceutical preparations for activating cellular function; human vaccine preparations; Anti-cancer preparations; Veterinary vaccines; Pharmaceutical agents for treating physically caused lesions; Bacteriological preparations for medical and veterinary use; Preparations of microorganisms for medical purposes; Bacterial preparations for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameONCOBIX CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR
Party NameONCOBIX CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR
Party NameONCOBIX CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Saturday, March 30, 2024NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 3, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 6, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 6, 2023FINAL DISPOSITION PROCESSED
Wednesday, September 6, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 6, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 6, 2023REGISTERED-PRINCIPAL REGISTER
Monday, May 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, March 21, 2023NOTIFICATION PROCESSED BY IB
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Monday, March 6, 2023REFUSAL PROCESSED BY IB
Wednesday, March 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 1, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 10, 2023EXAMINER'S AMENDMENT ENTERED
Friday, February 10, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 10, 2023EXAMINERS AMENDMENT E-MAILED
Friday, February 10, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2023NON-FINAL ACTION WRITTEN
Monday, January 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 29, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 29, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, December 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 29, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 23, 2022REFUSAL PROCESSED BY IB
Wednesday, August 3, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 3, 2022REFUSAL PROCESSED BY MPU
Tuesday, July 19, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 18, 2022NON-FINAL ACTION WRITTEN
Monday, July 18, 2022ASSIGNED TO EXAMINER
Friday, November 19, 2021APPLICATION FILING RECEIPT MAILED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

oncobix preparations pharmaceutical veterinary agents medical cancer purposes affecting vaccine anti